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The Environmental Health Summit was
held 1-4 June 1995 at Biosphere 2 in
Oracle, 30 miles north of Tucson, Arizona.
Nearly 30 scientists from across the country
gathered to formulate a new national blue-
print for addressing the nation's most urgent
environmental health research priorities. The
priorities were addressed by five committees:
1) children's health, 2) respiratory system, 3)
immune system, 4) nervous system, and 5)
reproductive system. The summit was a pub-
lic-private partnership between the nonprof-
it Environmental Health Foundation, the
National Institute of Environmental Health
Sciences, the Agency for Toxic Substances
and Disease Registry (ATSDR), and the
University of Arizona Health Sciences
Center. This meeting report provides a sum-
mary of research recommendations from
each ofthe summit committees.
Childrens Health
The differences in examining the effects of
environmental toxicants between children
and adults include differing patterns of
exposure, breathing, and dietary intake, as
well as differing biology of absorption, dis-
tribution, metabolism, and excretion of
these agents (implying different
exposure-dose relationships), rapid growth
and development of organ systems (imply-
ing different dose-response relationships);
and the projected longer life span of chil-
dren (14. These differences prompted the
committee to formulate the following rec-
ommendations.
Endocrine modifiers. The committee
stressed the need for increased research on
environmental endocrine modifiers in chil-
dren, especially the effects ofearly exposure
and intrauterine exposure in particular.
Outcomes of interest include sexual matu-
ration, altered thyroid function, and gen-
der-specific behaviors.
Neurodevelopmental outcomes. Research
should be conducted on the effects ofexpo-
sures to environmental agents in infants and
children and their neurodevelopmental out-
comes. Of particular interest are outcomes
for which there is already some limited evi-
dence ofenvironmental contributors: atten-
tion deficit hyperactivity disorder (ADHD),
mood disorders (depression and bipolar dis-
order), hyperagression and criminal behav-
iors, and infantile autism.
The agents of greatest interest for this
research should include metals, including
lead, mercury, cadmium, and manganese;
halogenated hydrocarbons, particularly
dioxins, organochlorine pesticides, and
PCBs; organic solvents, such as trichloro-
ethelyene (TCE) and benzene; air pollu-
tants, particularly their interactions with
infectious agents, such as respiratory syncy-
tial virus (RSV), and certain fungal agents;
and other environmental factors, such as
electromagnetic fields (EMF), radon gas,
ultraviolet light (UV), and sound (especial-
ly repeated exposure to high frequencies).
Lung development. Studies need to be
done regarding potential for permanent
impairment oflung function and structure
due to exposure to environmental haz-
ardous pollutants during infancy and early
childhood. Because the lung, like the ner-
vous system, has certain critical periods of
development and maturation, specific tim-
ing oflung injury could lead to permanent
morphologic alterations. Such alterations
may set the stage for lifelong impairment
and future susceptibility to adult lung dis-
eases such as asthma, emphysema, bronchi-
tis, and bronchiectasis.
Health andsocial costs. The committee
strongly recommended studies to deter-
mine the total costs to American society of
diseases related to environmental exposures
in children. This analysis should assess all
costs to include, but not be limited to lost
productivity over the lifetime of the child,
household costs such as lost parental wages,
costs ofhousehold disruption and divorce,
and costs of special education and the
many other corollary costs ofthe often per-
manent injuries that children suffer. (The
committee noted that in severely neurologi-
cally damaged children, families often have
a divorce rate greater than 90%, which has
devastating human and economic conse-
quences.) As a step toward understanding
the economic consequences ofenvironmen-
tal inequality, the committee also urged
that research be conducted on the interac-
tions between environmental injuries and
malnutritiorn, poverty, and social disadvan-
tage. Some important target effects would
include the nervous system, lung injury,
and environmental carcinogenesis.
Respiratory System
Lung diseases, when combined, are the
third leading cause of death in the United
States and are a leading cause of illness and
disability (5). Morbidity and mortality from
asthma are well-documented (5), and associ-
ated health care costs exceed $6 billion. Since
the major contribution to lung diseases is
cigarette smoking, these diseases are inher-
entlycontrollable, providing a huge opportu-
nity for prevention (6-8). Accordingly, this
committee focused on research leading to a
better understanding ofwhat environmental
exposure factors are important in the etiolo-
gy of lung disease. All research should be
human-oriented, interdisciplinary research
that contains careful, rigorous study design
and exposure assessment, including esti-
mates of target tissue dose and specific
effects. The Committee on the Respiratory
System recommended these research foci:
Complex exposures. In today's environ-
ment, people are exposed to air pollution,
pollen, and contaminant-containing materi-
als such as carpets, upholstery, and drapes.
Questions that arise from these complex
exposures include: How do these exposures
interact? Is it important for one exposure to
precede another? What triggers lung disease?
Multidisciplinary studies of exposure to
complex mixtures of pollutants and
bioaerosols (including both allergens and
infectious agents) are necessary, both in
actual environments and in exposure cham-
bers, to better understand the dose-response
relationships, additive effects, adjuvant
effects, cumulative exposure and dose, time
and disease outcome, as well as the respira-
tory consequences of the exposures to envi-
ronmental pollutants (particularly in asth-
ma). These studies should have appropriate
indoor and outdoor assessments of the pol-
lutant exposures, including particles and
gases, volatile organic compounds (VOCs),
pesticides, and bioaerosols.
Hostfactors. Some people will react to
exposure, some will not. Identifying impor-
tant host factors (predispositions/suscepti-
bilities) can help us understand the expo-
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sure-dose relationships in humans and
help identify other factors that may be
overlooked in some segments ofthe popu-
lation, such as genetics, nutritional status,
sociocultural factors, and socioeconomic
status. This research will help identify the
specific factors in the agent-host-environ-
ment interaction in disease etiology, which
will lead to preventive strategies and envi-
ronmental equity. There should be research
on host susceptibility and gene-environ-
ment interactions in relation to asthma and
other lung diseases in those individuals
with physiological and immunological
hyperresponsiveness, including nutritional
factors and familial and genetic factors.
Markers in the disease process. The
committee suggested that indicators of the
disease process also be included in research.
The committee addressed the problem of
relating effects ofacute exposures to effects
of chronic exposures and understanding
the complete process in order to link the
question oflow-level exposures to environ-
mental pollutants to the possibility of
chronic pulmonary effects.
Environmentally induced lung diseases
are the result of a process leading from
exposure, pollutant deposition, preclinical
biochemical and physiological effects, to
overt symptoms ofdiseases, including lung
cancer, chronic bronchitis, asthma, hyper-
sensitivity pneumonitis, and pulmonary
fibrosis. To prevent and treat such lung
diseases, biologic indicators ofeach step in
this process need to be developed. Such
markers ofexposure, dose, early effects, and
susceptibility need to be used in epidemio-
logic and clinical studies ofthese diseases.
It was also recommended that the
methodology for banking tissue specimens
for later molecular marker studies be devel-
oped to study markers of exposure, host
susceptibility, and these disease processes.
In conjunction, we need to address the
complex scientific and ethical issues facing
such analyses and the use oftheir results.
Evaluation ofenvironmental controls
and new sources. In addition to specific
pharmaceutical treatments for lung diseases,
an entire industry promoting environmental
controls (with, for example, air cleaners,
cleaning of ventilation systems) has
emerged. The efficiency of environmental
controls has yet to be established. Studies
examining the utility ofenvironmental con-
trol methods are needed. The scope would
necessarily include both engineering and
clinical efficacy. Research should also
include monitoring ofthe respiratory effects
ofpollutants from existing and new sources,
specifically construction and furnishing
materials (for example, newsynthetic fibers),
and consumer products in populations.
Immune System
The committee on the immune system
addressed three categories ofimmune-relat-
ed dysfunction: 1) immune suppression
associated with decreased resistance to
external pathogens and cancer, 2) autoim-
munity, and 3) inappropriate responses
(hypersensitivity) that may result in allergy
and/or autoimmunity (1,6,7,9,10,13).
Immunosuppression. Research on
immunosuppression should consist ofstud-
ies to determine whether low-level (back-
ground or near-background) exposures are
sufficient to affect the immune system in
humans. Such studies will require well-
designed, prospective immuno-epidemio-
logical studies that include sensitive, vali-
dated immunodiagnostic techniques and
standardized case definitions.
The committee addressed developmental
and susceptibility issues by emphasizing that
specialconsideration shouldbegiven to poten-
tially sensitive populations such as the elderly,
the very young, and possibly underserved
minorities, aswellas thecontribution ofgenet-
icpredisposition, malnutrition, and stress.
In studies of dose-response relation-
ships on immunosuppression, the commit-
tee suggested that, in order to determine
the biological relevance ofsmall changes in
immune function, additional data will be
needed on the quantitative relationships of
exposure-dose with immune function rela-
tionships and clinical disease outcomes, as
well as on the dose effects with interven-
tion (e.g., vaccine effectiveness). From an
epidemiological standpoint, even slight
changes in immune functions could equate
to significant increases in disease.
The committee recommended that
consideration should be given to both sys-
temic as well as regional immunosuppres-
sion and the potential clinical conse-
quences. For example, there is evidence
that breathing ozone alters lung immune
function, resulting in increased infections,
and UV exposure decreases the ability of
the immune system to inhibit skin cancers.
The committee emphasized that appro-
priate methodology is critical in assessing
environmentally induced diseases. The use
ofassays ofsoluble immune and inflamma-
tory medications, immunoactive substances
(e.g., low-molecular weight agents,
cytokines) is encouraged. Methods should
be used to obtain small-volume samples
that ease subject burden, using molecular
methods that maximize information
return. In addition to appropriate laborato-
ry methods, it is critical that appropriate
control populations be studied.
Autoimmunity. With the exception of
heavy metals (e.g., mercury, cadmium,
chromium), there are insufficient animal
data and still fewer human studies that
evaluate specific chemicals (such as halo-
genated hydrocarbons, pesticides, solvents),
complex mixtures (such as diesel and gaso-
line exhaust, tobacco smoke, alone or in
combination with antigens), genetic predis-
position, and molecular mechanisms that
would better explain toxic pollutants and
immune function interactions. Based on
the studies that do exist, which implicate
an immunologic mechanism after exposure
(such as occupational asthma due to low
molecular weight chemicals, chromium
allergy, formaldehyde sensitization), and
the possibility that other exposures result in
autoimmune illnesses (e.g., systemic lupus
erythmatosis; SLE), the committee posed
the following questions: 1) Are specific
substances associated with an increased
incidence or severity ofautoimmune disor-
ders? For instance, are alkenes such as TCE
and/or other solvents related to SLE?
Similar relationships could be found with
environmental agents as with drugs. 2) Are
there regional increases in autoantibodies,
and are they related to environmental
exposures? If so, are these autoantibodies
clinically relevant? How would we deter-
mine if they lead to autoimmune diseases?
For instance, do known neurotoxic sol-
vents, alone or in conjunction with viruses
or vaccines, also induce cellular changes
leading to autoantibody production, neural
damage (e.g., demyelination), and disease?
Are neurotoxins adjuvants for viral-related
autoimmunity (e.g., multiple sclerosis)? 3)
If exposure-autoimmunity relations were
determined, what are the possible immune
mechanisms by which environmental toxic
agents or UVB produce autoimmunity?
Also, what is the molecular basis of such
autoimmunity? 4) Can existing or new ani-
mal models of autoimmune disorders be
used to study induction or exacerbation of
autoimmune diseases by environmental
agents?
Hypersensitivity. The committee recom-
mended that hypersensitivity research be
conducted to determine which indoor air
pollutants trigger immune responses and
how these responses are related to symptoms
or illness. Questions concerning the role of
indoor air pollution in chronic fatigue,
headaches, depression, chemical sensitivity,
asthma, and allergy need to be answered.
There is a high degree of public awareness
and concern with respect to these possible
associations, and many of these concerns
have chemophobic overtones. Thus, the
committee strongly recommended that
'hypersensitivity research address the follow-
ing areas in a definitive manner: 1) Research
should incorporate human epidemiological
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studies, both prospective and retrospective,
which take advantage ofunfortunate "natur-
al experiments" (e.g., involving "problem"
buildings) and which include measures of
specific and general immune response. 2)
Hypersensitivity research, which lends itself
to multidisciplinary, controlled exposure
studies with humans, can provide strong
experimental evidence for an immune effect.
Both acdimatization and increased sensitivi-
ty should be taken into account in these
double-blinded, placebo-controlled chal-
lenge studies. 3) Attention should be given
in all human studies to the responses of
groups ofindividuals who appear more sen-
sitive to one or more substances, since they
may serve as sentinels for the general popu-
lation. 4) Relevant, objective biological
markers, including immunological, neuro-
logical, biochemical, and other measures
which may correlate with symptoms should
be sought. 5) Relevant animal models for
research and possible use as sentinels also
need to be developed.
Nervous System
It is widely recognized that neurotoxicant
effects can be measured at multiple levels of
nervous system organization. Cognitive,
motor, and sensory impairments are among
the most debilitating ofconditions and can
lead to reductions in job productivity,
increased accident risk, and contribute to
poor quality of life (1,3). Environmental
exposures to substances such as n-hexane
and toluene have also been implicated in
neurodegenerative disorders such as
Parkinson's disease, Alzheimer's disease,
and amyotrophic lateral sclerosis (ALS)
(11). Such impairments increase societal
costs, as they are major factors in nursing
home placement, disability, and loss of
independence. In addition, psychiatric
problems affect up to 40% ofthe American
population over a lifetime. Psychiatric epi-
demiological research has generally not
considered the possible role of neurotoxi-
cants. (Findings in occupational samples
are often confounded by litigation issues.)
Understanding the relationship between
environmental toxicants and the biochemi-
cal and physiological neuropsychiatric dis-
eases requires concerted epidemiological
analysis. The committee on the nervous
system prefaced their research recommen-
dations with six general themes: 1) impor-
tance of studying long-term, delayed, or
latent, rather than acute effects of both
high and low doses of neurotoxicants; 2)
need for evaluating subtle nervous system
effects, especially those from low-dose
exposures; 3) importance of assessing indi-
vidual differences and cross-species differ-
ences in susceptibility; 4) importance of
understanding the modulation of neuro-
toxicant effects by other factors, such as
age, gender, nutritional status, and disease
states; 5) the interdisciplinary and cost-
effective approach for studying the effects
of neurotoxicants by using existing human
population-based studies of neurotoxicant
exposures, and incorporating studies of
health effects, including measures ofcogni-
tion, behavior, and affect; and 6) signifi-
cance of using cross-species technologies
and resolution of mechanisms of neuroin-
toxication, facilitated by multidisciplinary
approaches. These themes led to the fol-
lowing recommendations.
Neurodegenerative disorders. Research
should be conducted to characterize the
role ofenvironmental neurotoxicants in the
initiation, progression, and/or exacerbation
of neurodegenerative disorders. The disor-
ders should include, but not be limited to,
Parkinson's disease, Alzheimer's disease,
andALS.
Quality oflife. Research should apply
repeated-measures methodologies in novel
ways to detect and evaluate the long-term
cognitive, motor, and sensory effects of
neurotoxicants across species. It is of para-
mount importance to study the impact of
toxic exposures on impairment offunctions
of daily living (such as driving, shopping,
using the telephone, performing one's job
responsibilities) and overall quality of life.
There are problems with using only stan-
dard neuropsychological tests, which are
designed to detect deficits on a one-time
Volume 104, Number2 February 1996 * Environmental Health Perspectives 212Meeting Report
- Environmental Health Summit
basis, and which also have limitations for
detecting deficits in persons with above-
average intelligence (such as might be
found in sick building syndrome popula-
tions). The committee suggested the use of
sensitive tests amenable to repetition over
time within a single session, or over multi-
ple sessions close in time that can measure
and track subtle and progressive neuropsy-
chological and neurophysiological changes
with time; and application of repeated-
measures approaches applied to studying
the long-term effects of acute, high-dose
exposures (e.g., accidental chemical spills)
and chronic, low-dose exposures (e.g.,
indoor air pollution).
Psychiatric and behavioral disorders.
Research should be done to determine the role
ofenvironmental neurotoxicants in the initia-
tion, progression, and/or exacerbation ofpsy-
chiatric and behavioral disorders, including
major depression, chronic low-grade depres-
sion, panic disorder, other anxiety disorders,
and impulse control disorders involving irri-
tability and violence. The committee stressed
the need for neuropsychiatric research to be
included in epidemiological studies of the
incidence, prevalence, and course ofsuch dis-
orders in existing population-based samples in
whom levels ofneurotoxicant exposures have
already been characterized. There is a need for
epidemiological research evaluating the associ-
ation between neurotoxicant exposures and
neuropsychiatric disorders in sampleswith not
only high-level, but also chronic low-level
neurotoxicant exposures and population-
based samples without motivational con-
founders. In the event that epidemiological
associations between specific neurotoxicants
and a subset ofneurological and psychiatric
disorders are found, and drawing upon prior
research in animal models, neurochemical and
other neurobiological mechanisms can be
used to develop more specific pharmacologic
treatments for these illnesses than is currently
possible.
Reproductive System
The Committee on the Reproductive
System considered health trends in human
reproduction, which included the following
reports (13-15): in men, a 40% decrease in
semen count over the last 20-50 years, an
increase in testicular cancer, a two- to three-
fold increase in undescended testes, and
increases in cancers of the prostate and
breast.; in women, an increase in breast can-
cer; "benign" uterine diseases such as
endometriosis and uterine fibroids are esti-
mated to affect close to 20% of women
between puberty and menopause; premature
ovarian failure is also ofconcern. Questions
remain as to howthese diseases and dysfunc-
tions are initiated. The best known example
of "endocrine-disrupting" chemicals are
those associated with, or mimicking, female
sex hormone activity, the "environmental
estrogens." Since a number of common
environmental chemicals have been shown
to behave as weak-acting estrogens (or, in
some cases, antiestrogens), these environ-
mental factors have been proposed as possi-
ble contributors to these reproductive dys-
functions.
Adverse andbeneficialeffects ofenviron-
mental chemicals. The committee's first
research recommendation is pragmatic, with
an emphasis on disease prevention and treat-
ment. Research should be conducted on the
application of fundamental biology and
chemistry to reproductive sciences and clini-
cal needs. Studies ofthe reproductive system
lag behind other sciences in using the most
modern of biotechnologies. Further, the
research on human reproduction should
specifically address the adverse as well as the
beneficial effects ofchemicals in the environ-
ment (including dietary factors) which inter-
act with hormones that have reproductive
significance. These effects could include
chemicals that mimic hormones, block hor-
mone action, change the metabolism ofnat-
ural hormones, and/or change a hormonally
important process (such as increase or
decrease a hormone receptor). The difficul-
ties of assessing the balance of these estro-
genic and antiestrogenic effects ofagents and
complex mixtures will require novel research
approaches. The study ofthe impact ofenvi-
ronmental estrogens on human reproductive
health would benefit from various basic, clin-
ical, and epidemiological approaches, and an
understanding ofthe effects ofenvironmen-
tal factors working like female sex hormones
is central to the issue ofthe environment and
women's health. In addition, the committee
suggested that the role ofhormonally active
xenobiotics in the development ofthe repro-
ductive system should beemphasized.
Development ofexposure/effect bio-
markers. Finally, the committee encour-
aged the development and use ofappropri-
ate biomarkers of exposure and effect for
environmental agents acting on the repro-
ductive system. This is a critically needed
area which could build on the knowledge
gained in the previous research recommen-
dations and be applied to human reproduc-
tive wellness in two important ways: the
fundamental new knowledge ofthe biology
and chemistry of reproductive organs and
processes should be used in a predictive
sense, and such an approach should lead to
biomarkers that reflect early alterations in
reproductive processes and tissues, thus
allowing for the successful development of
intervention or prevention strategies for the
enhancement ofreproductive health.
Conclusion
All research should be interdisciplinary
with careful and rigorous study design and
exposure assessment, including estimations
of target-tissue dose, toxicokinetics, and
specific health effects. Interactions of envi-
ronmental toxic agents and genetics should
be an important research priority. At-risk
groups, such as children and the elderly, as
well as other factors such as gender, nutri-
tional status, and socioeconomic status
need to become a focus in environmental
health research. All research proposals
should undergo rigorous peer review.
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